Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$116K Sell
764
-299
-28% -$49.8K ﹤0.01% 903
2026
Q1
$223K Sell
1,063
-313
-23% -$78.7K ﹤0.01% 706
2025
Q4
$391K Buy
1,376
+239
+21% +$74.7K ﹤0.01% 464
2025
Q3
$351K Sell
1,137
-10
-0.9% -$3.13K ﹤0.01% 474
2025
Q2
$360K Buy
1,147
+48
+4% +$13.9K ﹤0.01% 455
2025
Q1
$289K Buy
1,099
+229
+26% +$62K ﹤0.01% 499
2024
Q4
$227K Buy
870
+54
+7% +$13.6K ﹤0.01% 531
2024
Q3
$190K Buy
816
+347
+74% +$71.3K ﹤0.01% 592
2024
Q2
$80.4K Buy
469
+157
+50% +$28.3K ﹤0.01% 868
2024
Q1
$67.7K Buy
+312
New +$58.2K ﹤0.01% 805
2023
Q3
Sell
-50
Closed -$14.4K 604
2023
Q2
$14.4K Buy
+50
New +$15.2K ﹤0.01% 587

Other funds holding PODD

Mather Group's PODD Position: Q2 2026 in Review

Mather Group reduced its Insulet (PODD) stake by 28% in Q2 2026, selling an estimated $49.8K and leaving 764 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #903.

Mather Group first reported a position in PODD in Q2 2023 and has held it in 11 quarters since. The position peaked at $391K in Q4 2025. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Mather Group held 764 shares of Insulet worth $116K as of Q2 2026.
  • Mather Group sold 299 Insulet shares in Q2 2026, an estimated $49.8K.
  • Insulet made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #903 holding.
  • Mather Group first reported a position in Insulet in Q2 2023 and has held it in 11 quarters since.
  • Mather Group's Insulet position peaked at $391K in Q4 2025.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.